A carregar...
Risk of immune-related diarrhea with PD-1/PD-L1 inhibitors in different cancer types and treatment regimens
Objective: To compare the incidence and severity of diarrhea among different tumor types and treatment regimens, and also compared with CTLA-4 inhibitors in randomized controlled trials. Methods: MEDLINE, PMC database and EMBASE were retrieved until December 2018. Studies were eligible if they were...
Na minha lista:
| Publicado no: | J Cancer |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Ivyspring International Publisher
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6930395/ https://ncbi.nlm.nih.gov/pubmed/31892971 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/jca.32724 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|